Stocktoria
INTUITIVE SURGICAL INC ISRG
INTUITIVE SURGICAL INC (ISRG) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $10.1B at a 28.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.43 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-08-12 | Oppenheimer | Outperform (up) |
| 2026-07-30 | HSBC | Hold (down) |
| 2026-07-17 | Raymond James | Outperform (main) |
| 2026-07-17 | Piper Sandler | Overweight (reit) |
| 2026-07-17 | JP Morgan | Overweight (main) |
| 2026-07-17 | Mizuho | Neutral (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.38 |
| Retained earnings / assets | 0.343 |
| EBIT / assets | 0.144 |
| Equity / liabilities | 7.128 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 6/9 | 12.06 | 50.2 | +20.5% |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | 5/9 | 3.96 | 24.5 | +7.2% |
| EW | Edwards Lifesciences Corp | 6/9 | 9.6 | 48.7 | +11.5% |
| STE | STERIS plc | 9/9 | 4.5 | 26.9 | +8.7% |
| ALGN | ALIGN TECHNOLOGY INC | 6/9 | 4.56 | 31.1 | +0.9% |
| ENOV | Enovis CORP | 4/9 | -1.51 | — | +6.7% |
| MSA | MSA Safety Inc | 6/9 | 5.65 | 23.6 | +3.7% |
About INTUITIVE SURGICAL INC
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
FAQ
Is ISRG financially healthy?
INTUITIVE SURGICAL INC's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does ISRG pay a dividend?
No, INTUITIVE SURGICAL INC does not currently pay a dividend.
How profitable is ISRG?
In FY2025, INTUITIVE SURGICAL INC had a net margin of 28.4% and a return on equity of 15.9%.
Is ISRG overvalued or undervalued?
INTUITIVE SURGICAL INC trades at about 51.0× trailing earnings — below its 10-year norm (10-year range 36.9×–89.1×, median 67.3×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for ISRG?
The average Wall-Street price target for INTUITIVE SURGICAL INC is $477.25, about 18.9% above the recent price, from 29 analysts (consensus: buy).
Is ISRG a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on INTUITIVE SURGICAL INC: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 50.2×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.